Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy

Radiology

Volumn 206, Issue 2, 1998, Pages 491-498

  Filippi, Christopher G ^a   Sze, Gordon ^a   Farber, Steven J ^a   Shahmanesh, Maryam ^b   Selwyn, Peter A ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Brain, disease; Brain, MR; Brain, white matter

Indexed keywords

GADOLINIUM PENTETATE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COGNITION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINASE INHIBITION; VIRUS ENCEPHALITIS; WHITE MATTER;

EID: 0031915252     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.206.2.9457204     Document Type: Article

References (45)

1. Simpson DM, Berger JR. Neurological manifestations of HIV infection. Med Clin N Am 1996; 80:1363-1394.
2. Price RW. Neurological complications of HIV infection: HIV series. Lancet 1996; 348:445-452.
3. Gray F, Scaravelli F, Everall I, et al. Neuropathology of early HIV infection. Brain Pathol 1996; 6:1-15.
4. Levy R, Bresdon DE. Central nervous system dysfunction in the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1988; 1:41-64.
5. McArthur JC. Neurological manifestations of AIDS. Medicine 1987; 66:407-437.
6. Portegies P, Enting RH, de Gans J, et al. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam. AIDS 1993; 7:669-675.
7. Flowers CH, Mafee MF, Crowell R, et al. Encephalopathy in AIDS patients: evaluation with MR imaging. AJNR 1990; 11: 1235-1245.
8. Broderick DF, Wippold FJ, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR 1993; 161:177-181.
9. Manji H, Connolly S, McAllister R, et al. Serial MRI of the brain in asymptomatic patients infected with HIV. J Neurol Neurosurg Psychiatr 1994; 57:144-149.
10. Post MJ, Levin BE, Berger JR, Duncan R, Quencer RM, Calabro G. Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects. AJNR 1992; 13:359-370.
11. Olsen WL, Longo FM, Mills CM, Norman D. White matter disease in AIDS: findings at MR imaging. Radiology 1988; 169:445-448.
12. Post MJ, Tate LC, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR 1988; 151:373-380.
13. Alyward EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatr 1995; 152:987-994.
14. Tozzi V, Narciso P, Galgani S, et al. Effects of zidovudine in thirty patients with mild to end stage AIDS dementia complex. AIDS 1993; 7:683-692.
15. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993; 43:2245-2252.
16. Machlen J, Dunlope O, Liestol K, Dobloug JH, Goplen AK, Torvik A. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment. AIDS 1995; 9:1165-1169.
17. Deeks SG, Smith M, Holodniy M, Kahn J. HIV-1 protease inhibitors: a review for clinicians. JAMA 1997; 277:145-153.
18. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996; 276:146-153.
19. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995; 333:1534-1539.
20. Mileno MD, Tashima K, Farrar D, Elliot BD, Rich JD, Flanigan TP. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, 1997.
21. Sidtis JJ, Gatsonis C, Price RW, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 1993; 33:343-349.
22. Davis LE, Hjelle BL, Miller VE, et al. Early brain invasion in iatrogenic human immune deficiency syndrome. Neurology 1992; 42:1736-1739.
23. Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exper Neurol 1986; 45:635-646.
24. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex II: neuropathology. Ann Neurol 1986; 19:525-535.
25. Post MJ, Berger JR, Quencer RM. Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology 1991; 178:131-139.
26. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986; 19:517-524.
27. McArthur JC. Neurologic manifestations of AIDS. Medicine 1987; 66:407-434.
28. Epstein LG, Sharer LR, Gajdusek DC. Hypothesis: AIDS encephalopathy is due to primary and persistent infection of the brain with a human retrovirus of the lentivirus subfamily. Med Hypotheses 1986; 21:87-96.
29. Shaw GM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985; 227:177-182.
30. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 223: 1089-1093.
31. Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-I infection and AIDS dementia complex. Science 1988; 239:586-592.
32. Portegies P, de Gans J, Eange JMA, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 1989; 33:343-349.
33. Yarchoan R, Berg G, Brouwers P, et al. Response of human immunodeficiency virus-associated neurological disease to 3′-azido-2′3′-dideoxythymidine. Lancet 1987; I:132-135.
34. Yarchoan R, Thomas RV, Graham J, et al. Long-term administration of 3′-azido-2′3′-dideoxythymidine to patients with AIDS-related neurological disease. Ann Neurol 1988; 23(suppl):S82-S87.
35. Schmitt FA, Bigley JW, McKinnis R, et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS dementia complex. N Engl J Med 1988; 319:1573-1578.
36. Reinvang I, Froland SS, Karlsen NR, Lundervold AJ. Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine (letter). AIDS 1991; 5:228-229.
37. Clumeck N. Current use of anti-HIV drugs in AIDS. J Antimicrob Chemother 1993; 32(suppl A):133-138.
38. Demenie CA, Bechtold CM, Stock D, et al. Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication. Antimicrob Agents Chemother 1996; 40:1346-131.
39. Noble S, Fualds D. Saquinavir: a review of its pharmacology and clinical potential in the management of HIV infection. Drugs 1996; 52:93-112.
40. Cameron B, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS in advanced immunodeficiency with ritonavir. Presented at the Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 28 to February 1, 1996.
41. Heath-Chiozzi M, Leonard J, Henry D, et al. Anti-HIV activity and lymphocyte surrogate marker response dynamics to ritonavir therapy in advanced HIV immunodeficiency. Presented at the Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 28 to February 1, 1996.
42. Bugelski RJ, Kirsh R, Hart TK. HIV protease inhibitors: effects on viral maturation and physiologic function in macrophages. J Leucocyte Biol 1994; 56:374-380.
43. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991; 1:163-175.
44. Price RW, Sidtis JJ, Brew BJ. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol 1991; 1:155-162.
45. Hawkins CP, McLaughlin JE, Kendall BE, McDonald WI. Pathological findings correlated with MRI in HIV infection. Neuroradiology 1993; 35:264-268.